Helios' calcium ingredient NC-518 wins award

Helios' calcium ingredient NC-518 wins award

Helios CORP and their distribution partner, Summit Resource Group, recently received the National IFT global, 2011 Top Innovation and Technology Award at the opening, annual IFT ceremonies, June 12, in New Orleans. Receiving the award at opening ceremonies was the developer of the technology, Mr. Thomas Chang, of Sunbio Corporation

Helios CORP and their distribution partner, Summit Resource Group, recently received the National IFT global, 2011 "Top Innovation and Technology Award" at the opening, annual IFT ceremonies, June 12, in New Orleans. Receiving the award at opening ceremonies was the developer of the technology, Mr. Thomas Chang, of Sunbio Corporation.

The award was given for the branded ingredient called NC-518, a Novel Calcium for bone health. NC-518 was developed for the Nutritional Category and backed by a 30 month open label study and a recently completed, 12/2010, USA based, 4 month, Phase II, randomized, double blind, placebo controlled, human clinical study. The initial submission to the committee suggested that NC-518's potential in the functional foods category might be applicable to the Beverage, Dairy and Fortification categories. Backed by the two clinical studies the notion was that the end user might be able to make stronger structure function claims on the label, or referencing the benefits of "improved bone health" or even "increases bone density".

NC-518 achieved an average bone density increase of 2.2% over the four months time frame in the second clinical evaluation. All participants were tested before the beginning of the study and at completion of the second study, via Dexascan. The starting ingredient is Oyster Shell and the resulting ingredient is Calcium Carbonate. The process is key and we spent 6 years developing a Laser Micronization method applied with a continuous, electro-static charge during the production process. This patented technique creates a finished product where the Trace Mineral Complex and Zinc are fully utilized. This is key in creating the increases in bone density.

Helios CORP can provide a summary of the human clinical studies upon request. Summaries are available on the Helios web site, http://www.helioscorp.net/. Per the comments of Helios president, Michael Jeffers, “NC-518 is in uncharted territory within functional foods but based on the feedback of many food companies at the recent IFT convention and trade show, the science that created NC-518 will transform the Calcium fortification market for years to come".

About Helios

Helios Corp. is a privately owned and global company that develops new, nutritional ideas, science, and cultural remedies that can be translated into commercial applications for the benefit of nutra and food manufacturers and consumers. Helios branded ingredients come with Phase I and Phase II human clinical studies. Claims and representations are based on the information, data, clinical studies, and remedies as provided by our science and manufacturing partners.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish